sulfasalazine has been researched along with Diabetes Mellitus, Type 1 in 4 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Willsteed, E | 1 |
| Lee, M | 1 |
| Wong, LC | 1 |
| Cooper, A | 1 |
| Tack, CJ | 2 |
| Lutterman, JA | 1 |
| Wetzels, JF | 1 |
| Schmidt, M | 1 |
| Epstein, S | 1 |
| Maruta, K | 1 |
| Kawai, K | 1 |
| Burkart, V | 1 |
| Kiesel, U | 1 |
| Kolb, H | 1 |
4 other studies available for sulfasalazine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Sulfasalazine and dermatitis herpetiformis.
Topics: Administration, Oral; Adult; Aged; Anemia, Pernicious; Anti-Inflammatory Agents, Non-Steroidal; Derm | 2005 |
[Problems in the interpretation of the percentage of glycosylated hemoglobin in patients with diabetes mellitus].
Topics: Adult; Aged; Anemia, Hemolytic, Autoimmune; Anemia, Iron-Deficiency; Chromatography, High Pressure L | 1995 |
Decreased HbA1c levels due to sulfonamide-induced hemolysis in two IDDM patients.
Topics: Adult; Anti-Inflammatory Agents; Child; Diabetes Mellitus, Type 1; Female; Hemoglobin A; Hemolysis; | 1996 |
Modulation of arachidonic acid metabolism has limited effects on the development of type I diabetes in animal models.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Arachidonic Acid; Arachidonic | 1989 |